Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q1 2015 · 10-Q
Revenue$2.56B$2.56B+20.0% vs Q1 2014 Net Income$822.50M$822.50M+71.4% vs Q1 2014 EPS Diluted$3.49$3.49+72.8% vs Q1 2014 Gross Profit$2,242,600,000+21.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flow$733,000,000+600.6% Free Cash Flowderived$635,200,000+1,162.3% Margins · derivedGross margin87.8%+0.9 pt vs Q1 2014
Operating margin43.8%+12.2 pt vs Q1 2014
Net margin32.2%+9.7 pt vs Q1 2014
ended Mar 31, 2015 · filed Apr 24, 2015 · 24 d after period end